Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 691 to 705 of 811 results for adult social

  1. Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (TA406)

    Evidence-based recommendations on crizotinib (Xalkori) for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    28 September 2016
    View recommendations

    Sections for TA406

  2. Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs (TA225)

    Evidence-based recommendations on golimumab (Simponi) for treating rheumatoid arthritis in adults.

    Technology appraisal guidance
    Published
    22 June 2011
    View recommendations

    Sections for TA225

  3. Care pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance misuse?

    pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance...

    Research recommendation
    Published
    10 February 2017

  4. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    interpersonal interactions and relationships, major life areas, community, and social and civil life. There is evidence suggesting that...

    Research recommendation
    Published
    26 October 2020

  5. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    profile, psychological symptoms, childhood adversity, psychiatric history, social supports, quality of life and other relevant potential...

    Research recommendation
    Published
    9 June 2015

  6. QTUG for assessing falls risk and frailty (MIB73)

    NICE has developed a medtech innovation briefing (MIB) on the Quantitative Timed Up and Go (QTUG)

    Medtech innovation briefing
    Published
    26 July 2016

  7. Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy (HST24)

    Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating presymptomatic spinal muscular atrophy in babies aged 12 months and under.

    Highly specialised technologies guidance
    Published
    19 April 2023
    View recommendations

    Sections for HST24

  8. i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

    NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department

    Medtech innovation briefing
    Published
    9 September 2015

  9. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  10. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  11. Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance misuse to obtain an optimal service (including optimal time frame for delivering interventions) to meet their needs and enable their recovery?

    facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance...

    Research recommendation
    Published
    10 February 2017

  12. People who choose not to take antipsychotic medication:- What is the clinical and cost effectiveness of psychological intervention alone, compared with treatment as usual, in people with psychosis or schizophrenia who choose not to take antipsychotic medication?

    include symptoms, relapse rates, quality of life, treatment acceptability, social functioning and the cost effectiveness of the...

    Research recommendation
    Published
    9 June 2015

  13. Team composition for home-based intermediate care:- How effective and cost effective are different approaches, in terms of team structure and composition, to providing home-based intermediate care for adults?

    structure and composition, to providing home-based intermediate care for adults? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    15 October 2018

  14. Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA327)

    Evidence-based recommendations on dabigatran etexilate (Pradaxa) for treating and preventing deep vein thrombosis and pulmonary embolism in adults.

    Technology appraisal guidance
    Published
    17 December 2014
    View recommendations

    Sections for TA327

  15. The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)

    NICE has developed a Medtech Innovation Briefing (MIB) on the hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability

    Medtech innovation briefing
    Published
    11 August 2014